Author

Steven L. Zeichner

University of VirginiaORCID 0000-0002-8922-9260Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein design· 1

Frequent Co-Authors

Andrei V. Khokhlatchev· 1 shared Anuradha IllendulaiD· 1 shared Claude Chew· 1 shared David D. HoiD· 1 shared Denicar Lina Nascimento Fabris MaedaiD· 1 shared Frances MehliD· 1 shared Ginette SerreroiD· 1 shared Hanna YuiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Andrei V. Khokhlatchev

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ACE-2-like Enzymatic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal Antibodies

Yufeng Song, Frances Mehl, Tom J. No, Lauren Livingston, Juan Sebastián Quintero, Jun Hayashi, Ginette Serrero, Pamela D. Schoppee, Jeffrey M. Wilson, James E. Crowe, David D. Ho, Michael T. Yin, Joshua Tan, Steven L. Zeichner

This study identifies monoclonal antibodies with ACE2-like catalytic activity that may contribute to post-acute sequelae of COVID-19.

bioRxiv · Apr 23, 2026 · PreprintMicrobiology

Minicells from Highly Genome Reduced Escherichia coli: Cytoplasmic and Surface Expression of Recombinant Proteins and Incorporation in the Minicells

Hanna Yu, Andrei V. Khokhlatchev, Claude Chew, Anuradha Illendula, Mark R. Conaway, Kelly A. Dryden, Denicar Lina Nascimento Fabris Maeda, Vignesh Rajasekaran, MARK A. KESTER, Steven L. Zeichner

The paper combines genome-reduced E. coli with min mutants to produce minicells that concentrate recombinant proteins for biotechnological applications.

ACS Synthetic Biology · Sep 13, 2021Peer-reviewedSynthetic Biology